This live, one-hour event was designed exclusively for Health or Social Care workers, and those who support patients with memory concerns, Mild Cognitive Impairment, or Alzheimer’s disease. It provided practical updates and expert perspectives to help you feel more informed when discussing research opportunities and new treatment pathways with your patients.

The session was hosted by Anna Borthwick, Director of Engagement, with expert insights from Dr Sarah Gregory, Principal Investigator, and Dr Miles Welstead, Head of Cognitive Sciences.

During the webinar, we covered:

• Current Alzheimer’s clinical trials and how they are shaping future treatment options
• Updates on new therapies and access pathways across Scotland
• The growing importance of cognitive sciences in identifying and supporting people at risk earlier than ever before